MAKING HEARING A PRIORITY
CILcare is the world’s leading R&D services company committed to making hearing a priority. Take an in-depth look at how we can support your R&D program to prevent and treat ear disorders.
Discover our services
Discover the article issued this month in World Pharma Today ! It discusses advances in understanding of auditory pathways and discrete mechanisms underlying auditory function, as well as recent research in stem cells and regenerative medicine strongly suggesting that...
We are pleased to present you our new website: enjoy discovering our new pages !
CILcare invites you in Basel to a first-of-its-kind workshop about the auditory system dysfunctions, May 2018
Register by May 9th to attend !
Pharma / Biotech
Develop new therapies.
Repurpose existing drugs in otology.
Innovate with drug delivery devices for the inner ear.
Speed up market access of hearing aids.
Develop health food ingredients for the prevention of hearing loss, tinnitus, or otitis.
Improve and develop products to treat ear inflammation in pets.
CILcare, the world leading CRO dedicating to ear disorders
CILcare is a unique R&D services company specializing in ear disorders.
We offer preclinical services and consultancy to accelerate the development of innovative products for hearing loss, tinnitus, and otic disorders.
Nadia Pilati, Ph.D. Senior Electrophysiologist, Autifony Therapeutics Ltd
Carmen Herrero, CSO, Spiral Therapeutics
Senior Director, Future Pipeline Discovery,Top ten pharmaceutical company
Hiroshi Uchino Ph.D, Senior Researcher, Astellas Pharma Inc.